Science Explorer Back to mapMap
Discussion
Company · Lexington · United States

Inotek Pharmaceuticals (United States)

In research, Inotek Pharmaceuticals (United States) stands highest in Engineering (#6,689 of 9,532 worldwide) and Physical Sciences (#12,818 of 17,446 worldwide), over all time.

World rank, all time
#15,764
of 34,923
Rank in United States
#3,253
of 7,310
Research works
690
▼ 8% vs 2018-21
Citations
20k
28.5 per fractional work
Top-10% rate
7.6%
all institutions 10.0%
vs its own fields
0.98×
1.00× is exactly expected
Open access
16%
world 40%
International
11%
world 18%

What is Inotek Pharmaceuticals (United States) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
EngineeringField #6,689 of 9,532 10.6%265
Physical SciencesDomain #12,818 of 17,446 11.4%497

Each strip is that field's whole ranked pool, with the notch where Inotek Pharmaceuticals (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Inotek Pharmaceuticals (United States) work in?

In all years, 72% of research at Inotek Pharmaceuticals (United States) is in Physical Sciences, 14% in Health Sciences. Its largest fields are Engineering (38%), Physics and Astronomy (16%), Medicine (13%). It does 1.8× the world's share of Physical Sciences.

Physical Sciences: 497 fractional works · 72.1% of its workEngineering: 265 fractional works · 38.4% of its workElectrical and Electronic Engineering: 93 fractional works · 13.5% of its workBiomedical Engineering: 45 fractional works · 6.5% of its workMechanical Engineering: 30 fractional works · 4.4% of its workAerospace Engineering: 26 fractional works · 3.7% of its workComputational Mechanics: 25 fractional works · 3.6% of its workMedia Technology: 14 fractional works · 2.0% of its workOcean Engineering: 9 fractional works · 1.4% of its workMechanics of Materials: 7 fractional works · 1.0% of its workCivil and Structural Engineering: 6 fractional works · 0.9% of its workIndustrial and Manufacturing Engineering: 5 fractional works · 0.7% of its workControl and Systems Engineering: 3 fractional works · 0.5% of its workSmaller subfields together: 2 fractional works · 0.3% of its workPhysics and Astronomy: 108 fractional works · 15.7% of its workAtomic and Molecular Physics, and Optics: 81 fractional works · 11.8% of its workAstronomy and Astrophysics: 9 fractional works · 1.3% of its workInstrumentation: 7 fractional works · 1.0% of its workRadiation: 4 fractional works · 0.6% of its workStatistical and Nonlinear Physics: 4 fractional works · 0.5% of its workCondensed Matter Physics: 2 fractional works · 0.3% of its workNuclear and High Energy Physics: 2 fractional works · 0.2% of its workComputer Science: 45 fractional works · 6.6% of its workComputer Vision and Pattern Recognition: 27 fractional works · 3.9% of its workArtificial Intelligence: 8 fractional works · 1.2% of its workInformation Systems: 3 fractional works · 0.4% of its workComputational Theory and Mathematics: 2 fractional works · 0.3% of its workSmaller subfields together: 5 fractional works · 0.7% of its workMaterials Science: 38 fractional works · 5.5% of its workMaterials Chemistry: 17 fractional works · 2.4% of its workSurfaces, Coatings and Films: 12 fractional works · 1.8% of its workElectronic, Optical and Magnetic Materials: 4 fractional works · 0.6% of its workCeramics and Composites: 3 fractional works · 0.4% of its workPolymers and Plastics: 2 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.1% of its workEarth and Planetary Sciences: 10 fractional works · 1.5% of its workAtmospheric Science: 3 fractional works · 0.5% of its workGeology: 2 fractional works · 0.4% of its workOceanography: 2 fractional works · 0.3% of its workSmaller subfields together: 3 fractional works · 0.4% of its workChemistry: 9 fractional works · 1.3% of its workOrganic Chemistry: 4 fractional works · 0.6% of its workSpectroscopy: 2 fractional works · 0.3% of its workAnalytical Chemistry: 2 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.2% of its workMathematics: 8 fractional works · 1.2% of its workApplied Mathematics: 3 fractional works · 0.5% of its workGeometry and Topology: 2 fractional works · 0.2% of its workSmaller subfields together: 4 fractional works · 0.5% of its workEnergy: 6 fractional works · 0.9% of its workRenewable Energy, Sustainability and the Environment: 6 fractional works · 0.9% of its workEnvironmental Science: 5 fractional works · 0.8% of its workEnvironmental Engineering: 2 fractional works · 0.2% of its workSmaller subfields together: 4 fractional works · 0.5% of its workChemical Engineering: 1 fractional works · 0.2% of its workHealth Sciences: 93 fractional works · 13.5% of its workMedicine: 86 fractional works · 12.5% of its workOncology: 20 fractional works · 2.9% of its workCardiology and Cardiovascular Medicine: 8 fractional works · 1.2% of its workSurgery: 7 fractional works · 1.0% of its workPhysiology: 7 fractional works · 1.0% of its workOphthalmology: 6 fractional works · 0.9% of its workPathology and Forensic Medicine: 6 fractional works · 0.9% of its workPulmonary and Respiratory Medicine: 4 fractional works · 0.6% of its workRadiology, Nuclear Medicine and Imaging: 4 fractional works · 0.6% of its workEpidemiology: 3 fractional works · 0.4% of its workPublic Health, Environmental and Occupational Health: 3 fractional works · 0.4% of its workPharmacology: 2 fractional works · 0.3% of its workComplementary and alternative medicine: 2 fractional works · 0.3% of its workNeurology: 2 fractional works · 0.2% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 0.2% of its workSmaller subfields together: 11 fractional works · 1.5% of its workHealth Professions: 4 fractional works · 0.5% of its workNursing: 3 fractional works · 0.4% of its workNutrition and Dietetics: 3 fractional works · 0.4% of its workVeterinary: 1 fractional works · 0.1% of its workLife Sciences: 62 fractional works · 9.0% of its workBiochemistry, Genetics and Molecular Biology: 36 fractional works · 5.3% of its workMolecular Biology: 17 fractional works · 2.5% of its workPhysiology: 7 fractional works · 1.0% of its workGenetics: 4 fractional works · 0.5% of its workBiophysics: 3 fractional works · 0.4% of its workCancer Research: 2 fractional works · 0.3% of its workBiochemistry: 1 fractional works · 0.2% of its workSmaller subfields together: 3 fractional works · 0.4% of its workImmunology and Microbiology: 10 fractional works · 1.5% of its workImmunology: 10 fractional works · 1.5% of its workNeuroscience: 8 fractional works · 1.1% of its workCognitive Neuroscience: 2 fractional works · 0.3% of its workNeurology: 2 fractional works · 0.3% of its workSmaller subfields together: 3 fractional works · 0.5% of its workAgricultural and Biological Sciences: 7 fractional works · 1.0% of its workFood Science: 2 fractional works · 0.3% of its workInsect Science: 2 fractional works · 0.2% of its workSmaller subfields together: 3 fractional works · 0.5% of its workPharmacology, Toxicology and Pharmaceutics: 2 fractional works · 0.2% of its workSocial Sciences: 37 fractional works · 5.4% of its workSocial Sciences: 13 fractional works · 1.9% of its workPolitical Science and International Relations: 4 fractional works · 0.6% of its workEducation: 3 fractional works · 0.5% of its workSociology and Political Science: 2 fractional works · 0.3% of its workSmaller subfields together: 4 fractional works · 0.6% of its workArts and Humanities: 6 fractional works · 0.9% of its workVisual Arts and Performing Arts: 3 fractional works · 0.4% of its workSmaller subfields together: 4 fractional works · 0.6% of its workBusiness, Management and Accounting: 6 fractional works · 0.9% of its workManagement Information Systems: 2 fractional works · 0.3% of its workStrategy and Management: 2 fractional works · 0.2% of its workSmaller subfields together: 3 fractional works · 0.4% of its workPsychology: 5 fractional works · 0.8% of its workSocial Psychology: 4 fractional works · 0.5% of its workSmaller subfields together: 2 fractional works · 0.3% of its workDecision Sciences: 3 fractional works · 0.5% of its workStatistics, Probability and Uncertainty: 3 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEconomics, Econometrics and Finance: 2 fractional works · 0.4% of its workEconomics and Econometrics: 2 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workALL ITS WORKInotekPharmaceuticals…690fractional works, all years
Life Sciences9%Physical Sciences72%Health Sciences14%Social Sciences5%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 26 fields, with their numbers
    1. Engineering26538.4%
    2. Physics and Astronomy10815.7%
    3. Computer Science456.6%
    4. Materials Science385.5%
    5. Earth and Planetary Sciences101.5%
    6. Chemistry91.3%
    7. Mathematics81.2%
    8. Energy60.9%
    9. Environmental Science50.8%
    10. Chemical Engineering10.2%
    1. Medicine8612.5%
    2. Health Professions40.5%
    3. Nursing30.4%
    4. Veterinary10.1%
    5. Dentistry00.0%
    1. Biochemistry, Genetics and Molecular Biology365.3%
    2. Immunology and Microbiology101.5%
    3. Neuroscience81.1%
    4. Agricultural and Biological Sciences71.0%
    5. Pharmacology, Toxicology and Pharmaceutics20.2%
    1. Social Sciences131.9%
    2. Arts and Humanities60.9%
    3. Business, Management and Accounting60.9%
    4. Psychology50.8%
    5. Decision Sciences30.5%
    6. Economics, Econometrics and Finance20.4%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 2.25× its world share, 2 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.53× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 0.66× its world share, 0 worksImmunology and Micro…Neuroscience: 4.54× its world share, 1 worksNeuroscienceChemistry: 1.70× its world share, 0 worksChemistryComputer Science: 0.25× its world share, 0 worksComputer ScienceEngineering: 1.10× its world share, 3 worksEngineeringEnvironmental Science: 0.86× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.85× its world share, 1 worksMaterials ScienceMathematics: 0.50× its world share, 0 worksMathematicsPhysics and Astronomy: 2.39× its world share, 1 worksPhysics and AstronomyHealth Professions: 0.49× its world share, 0 worksHealth ProfessionsMedicine: 1.05× its world share, 4 worksMedicineVeterinary: 0.52× its world share, 0 worksVeterinaryArts and Humanities: 0.36× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.55× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 0.83× its world share, 0 worksEconomics, Econometr…Psychology: 0.19× its world share, 0 worksPsychologySocial Sciences: 0.96× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Neuroscience, 4.5×. Every wedge is a field page.

All 19 fields, with their numbers
  1. Neuroscience4.54×1 works
  2. Physics and Astronomy2.39×1 works
  3. Agricultural and Biological Sciences2.25×2 works
  4. Chemistry1.70×0 works
  5. Biochemistry, Genetics and Molecular Biology1.53×2 works
  6. Engineering1.10×3 works
  7. Medicine1.05×4 works
  8. Social Sciences0.96×2 works
  9. Environmental Science0.86×1 works
  10. Materials Science0.85×1 works
  11. Economics, Econometrics and Finance0.83×0 works
  12. Immunology and Microbiology0.66×0 works
  13. Business, Management and Accounting0.55×0 works
  14. Veterinary0.52×0 works
  15. Mathematics0.50×0 works
  16. Health Professions0.49×0 works
  17. Arts and Humanities0.36×0 works
  18. Computer Science0.25×0 works
  19. Psychology0.19×0 works

Who are the top researchers at Inotek Pharmaceuticals (United States)?

Ranked on the quality score, Jon G. Mabley, Garry J. Southan and Anita Marton lead among researchers whose main affiliation is Inotek Pharmaceuticals (United States).

  1. 1 Jon G. Mabley United States · #899,709 worldwide 8.1k citations · 98 works
  2. 2 Garry J. Southan United States · #1,530,424 worldwide 5k citations · 84 works
  3. 3 Anita Marton United States · #1,804,892 worldwide 2.4k citations · 21 works
  4. 4 Kanneganti G. K. Murthy United States · #1,951,175 worldwide 3.8k citations · 33 works
  5. 5 Prakash G. Jagtap United States · #2,557,796 worldwide 6.3k citations · 65 works
  6. 6 R. E. Aldrich United States · #4,019,760 worldwide 491 citations · 22 works
  7. 7 Herbert A. Waggener United States · #4,179,489 worldwide 234 citations · 17 works
  8. 8 John W Hardy United States · #4,241,790 worldwide 1.7k citations · 40 works
  9. 9 Cadmus Collins Rich United States · #4,422,416 worldwide 200 citations · 24 works
  10. 10 I. C. Chang United States · #4,483,992 worldwide 1.4k citations · 89 works
All ranked researchers at Inotek Pharmaceuticals (United States)

What are the most cited papers from Inotek Pharmaceuticals (United States)?

The most cited paper from Inotek Pharmaceuticals (United States) is "The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors" (László Virág, Csaba Szabó, 2002), with 1,378 citations. Next come "Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors" (902) and "Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells" (806).

Most cited papers
#PaperReleasedCitations
1 The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors László Virág, Csaba Szabó · Pharmacological Reviews Sep 2002 1,378
2 Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors Prakash G. Jagtap, Csaba Szabó · Nature Reviews Drug Discovery Review 29 Apr 2005 902
3 Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells Xueliang Du, Takeshi Matsumura, Diane Edelstein et al. · Journal of Clinical Investigation Open access Oct 2003 806
4 Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation Francisco García Soriano, László Virág, Prakash G. Jagtap et al. · Nature Medicine Open access 2001 605
5 Adenosine inhibits IL‐12 and TNF‐α production via adenosine A 2a receptor‐dependent and independent mechanisms György Haskó, David G. Kuhel, Jiang‐Fan Chen et al. · The FASEB Journal Oct 2000 518
All 59 most cited papers, with filters and sorting

Which keywords describe research at Inotek Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Optical Modulators, Spectroscopy, Imaging, Adaptive Optics, Wavefront Sensing, Integrated Circuits, Raman Lasers and Silicon Photonics.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Optical Modulators36▲ 25×2 topics
  2. Spectroscopy32▲ 14×6 topics
  3. Imaging32▲ 13×5 topics
  4. Remote Sensing31▲ 4.1×16 topics
  5. Adaptive Optics28▲ 198×1 topic
  6. Wavefront Sensing28▲ 198×1 topic
  7. Integrated Circuits26▲ 16×2 topics
  8. Biosensors25▲ 6.4×4 topics
  9. Raman Lasers25▲ 21×2 topics
  10. Cancer Therapy24▲ 5.6×8 topics
  11. Silicon Photonics24▲ 22×2 topics
  12. Microcavities24▲ 22×1 topic
  13. Nanophotonic Waveguides24▲ 24×1 topic
  14. Cell Death23▲ 16×4 topics
  15. Photonic Crystals22▲ 21×3 topics
  16. Image Processing22▲ 9.8×5 topics
  17. Reactive Oxygen Species21▲ 6.0×10 topics
  18. Near-Infrared20▲ 47×2 topics
  19. Acousto-Optic20▲ 182×1 topic
  20. Crystals20▲ 182×1 topic
  21. Machine Tools20▲ 37×2 topics
  22. Structured Light19▲ 45×2 topics
  23. Homologous Recombination19▲ 40×2 topics
  24. Machine Vision18▲ 14×4 topics
  25. BRCA Mutation18▲ 156×1 topic
  26. PARP Inhibitors18▲ 156×1 topic
  27. Camera Calibration18▲ 66×1 topic
  28. Dimensional Metrology18▲ 75×1 topic
  29. Error Compensation18▲ 75×1 topic
  30. Fringe Projection18▲ 66×1 topic
  31. Compound Eyes16▲ 174×1 topic
  32. Freeform Optics16▲ 174×1 topic
  33. Semiconductor16▲ 7.2×5 topics
  34. Nanofabrication16▲ 26×2 topics
  35. Frequency Conversion16▲ 23×3 topics
  36. Wavelet Transform15▲ 11×3 topics
  37. Nonlinear Optics14▲ 12×2 topics
  38. Solar Cells13▲ 6.3×5 topics
  39. Microresonators12▲ 14×2 topics
  40. Lithium Niobate12▲ 52×1 topic

Which research topics does Inotek Pharmaceuticals (United States) publish most on?

By volume in 2022-now: Neurological Disorders and Treatments, Insect and Pesticide Research, Insect and Arachnid Ecology and Behavior and Bee Products Chemical Analysis.

  1. 1 Neurological Disorders and Treatments Neurology 1 works
  2. 2 Insect and Pesticide Research Insect Science 1 works
  3. 3 Insect and Arachnid Ecology and Behavior Genetics 0 works
  4. 4 Bee Products Chemical Analysis Insect Science 0 works
  5. 5 Heat Transfer and Optimization Mechanical Engineering 0 works
  6. 6 Digital Transformation in Industry Industrial and Manufacturing Engineering 0 works
  7. 7 Particle accelerators and beam dynamics Aerospace Engineering 0 works
  8. 8 Legal and Policy Analysis in Indonesia Law 0 works
  9. 9 Public Health and Nutrition Pediatrics, Perinatology and Child Health 0 works
  10. 10 Nanofluid Flow and Heat Transfer Biomedical Engineering 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available15.7%not open84.3%

World: 40% of research is openly available.

with international co-authors11.3%domestic only88.7%

World: 18% is written across borders.

How has Inotek Pharmaceuticals (United States)'s research output changed?

Output in 2022-2025 was 8% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Inotek Pharmaceuticals (United States) as a percentage of every work published that year, 0.000034% in 2024.

still counting0.0050%0.010%0.015%Inotek Pharmaceuticals (United States)0.000086% in 202519801990200020102020

Fractional works of Inotek Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Lexington

All research institutions in Lexington

Share Inotek Pharmaceuticals (United States)'s ranking

Inotek Pharmaceuticals (United States) on Science Explorer

A card with Inotek Pharmaceuticals (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Inotek Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.